Morgan Stanley’s Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant CPUH.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-315
Closed -$3K 8114
2022
Q1
$3K Sell
315
-2,500
-89% -$24.7K ﹤0.01% 7704
2021
Q4
$28K Hold
2,815
﹤0.01% 7082
2021
Q3
$28K Sell
2,815
-119
-4% -$1.19K ﹤0.01% 6969
2021
Q2
$30K Hold
2,934
﹤0.01% 6865
2021
Q1
$29K Buy
+2,934
New +$30.9K ﹤0.01% 6587

Other funds holding CPUH.U

Morgan Stanley's CPUH.U Position: Q2 2022 in Review

Morgan Stanley sold out of Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant (CPUH.U) in Q2 2022, closing a stake of 315 shares — an estimated $3K sold.

Morgan Stanley first reported a position in CPUH.U in Q1 2021 and held it in 5 quarters. The position peaked at $30K in Q2 2021. 38 funds tracked by Wall St. Rank hold CPUH.U as of Q2 2022.

  • Morgan Stanley reported no remaining Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant position as of Q2 2022 after selling out during the quarter.
  • Morgan Stanley sold 315 Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant shares in Q2 2022, an estimated $3K.
  • Morgan Stanley first reported a position in Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant in Q1 2021 and held it in 5 quarters.
  • Morgan Stanley's Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant position peaked at $30K in Q2 2021.
  • 38 funds tracked by Wall St. Rank held Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant as of Q2 2022.

Based on Morgan Stanley's 13F filing for Q2 2022, filed 15 Aug 2022.